Moreover, TNFα inhibition decreases the severity of arthritis, and both monoclonal antibodies to TNFα and a soluble tumor necrosis factor receptor analog have been used as effective therapies for RA and for other types of inflammatory arthritis [5-8]. The gene discussed is TNF; the disease is rheumatoid arthritis.